---
title: Phosphodiesterase-5 Inhibitor Treatment is Associated with Improved Survival
  in Pulmonary Hypertension Associated with COPD in the PVRI GoDeep Meta-Registry
date: '2024-08-25'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39182575/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240826183747&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'BACKGROUND: Patients with COPD frequently develop pulmonary hypertension
  (PH-COPD). Severe PH-COPD, identified by a pulmonary vascular resistance (PVR) >5
  Wood Units (WU), is closely linked to impaired transplant-free survival. The impact
  of PH-targeting pharmacotherapy in this context remains ...'
disable_comments: true
---
BACKGROUND: Patients with COPD frequently develop pulmonary hypertension (PH-COPD). Severe PH-COPD, identified by a pulmonary vascular resistance (PVR) >5 Wood Units (WU), is closely linked to impaired transplant-free survival. The impact of PH-targeting pharmacotherapy in this context remains ...